Corbus Pharmaceuticals Holdi

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.25

+0.18 (+1.98%)

As of Jul 4, 2:14 AM ET ·

CRBP vs Biotechnology Average

Profit Margin

CRBP -3.5%

Avg -197.5%

Rev Growth

CRBP +4.2%

Avg +13.1%

Biotechnology Peers

1012 stocks in sector

Symbol	Name	Price	Change %	Market Cap	P/E	Margin	Growth	Div Yield	Analyst
CRBP	Corbus Pharmaceuticals Holdi	$9.25	+1.98%	171.38M	—	-3.5%	+4.2%	—	Current
ABBV	Abbvie Inc	$261.07	+3.99%	461.26B	126.9	6.9%	+1.8%	2.65%	Strong buy	Compare
AMGN	Amgen Inc	$374.15	+3.55%	201.93B	25.9	21.0%	+11.8%	2.69%	Hold	Compare
GILD	Gilead Sciences Inc	$131.27	+4.21%	162.98B	17.7	28.9%	+2.6%	2.50%	Strong buy	Compare
VRTX	Vertex Pharmaceuticals Inc	$528.04	+6.03%	131.79B	30.4	32.9%	+10.4%	—	Strong buy	Compare
REGN	Regeneron Pharmaceuticals	$654.27	+4.73%	68.59B	15.5	31.4%	+5.6%	0.57%	Buy	Compare
ALNY	Alnylam Pharmaceuticals Inc	$312.78	+3.68%	41.76B	72.4	8.5%	+53.0%	—	Strong buy	Compare
RVMD	Revolution Medicines Inc	$189.24	+0.92%	40.23B	—	4.4%	+0.4%	—	Strong buy	Compare
NTRA	Natera Inc	$279.32	+1.10%	40.00B	—	-9.0%	+41.1%	—	Strong buy	Compare
BIIB	Biogen Inc	$216.12	+3.04%	31.91B	23.3	13.1%	-0.9%	—	Buy	Compare
MRNA	Moderna Inc	$79.76	+10.01%	31.65B	—	-145.2%	-53.4%	—	Hold	Compare
ROIV	Roivant Sciences Ltd	$35.13	+0.29%	25.27B	—	-3,629.2%	-48.7%	—	Strong buy	Compare
INSM	Insmed Inc	$111.60	+4.30%	24.19B	—	-210.5%	+35.2%	—	Strong buy	Compare
UTHR	United Therapeutics Corp	$555.91	+1.60%	23.60B	18.3	41.9%	+18.0%	—	Strong buy	Compare
INCY	Incyte Corp	$116.86	+2.68%	23.35B	16.3	25.0%	+14.8%	—	Hold	Compare
EXAS	Exact Sciences Corp	$104.91	+0.95%	20.03B	—	-6.4%	+15.9%	—	Hold	Compare
NBIX	Neurocrine Biosciences Inc	$174.26	+3.87%	17.52B	26.2	16.7%	+24.3%	—	Strong buy	Compare
BBIO	Bridgebio Pharma Inc	$77.19	+3.58%	15.12B	—	-144.4%	+86.3%	—	Strong buy	Compare
EXEL	Exelixis Inc	$55.85	+3.50%	14.04B	16.8	33.7%	+12.9%	—	Buy	Compare
IONS	Ionis Pharmaceuticals Inc	$81.80	+3.30%	13.52B	—	-40.4%	+17.1%	—	Strong buy	Compare
MDGL	Madrigal Pharmaceuticals Inc	$528.10	+2.67%	12.18B	—	-30.1%	—	—	Strong buy	Compare